Zimmer Biomet receives FDA 510(k) clearance for revision knee replacement system
Zimmer Biomet Holdings Inc. announced it received FDA 510(k) clearance for the Persona Revision Knee System.
According to a company press release, Zimmer Biomet plans to launch the system in the United States within the next few weeks. The system allows surgeons to take a personalized approach to perform complex revision procedures. The system uses Zimmer Biomet’s trabecular metal technology and Vivacit-E highly crosslinked polyethylene.
“Persona Revision completes Zimmer Biomet's flagship Persona knee system and enhances our ecosystem of customer-centric solutions that address the needs of our customers and improve patient outcomes,” Ivan Tornos, Zimmer Biomet’s group president of global orthopedics, said in the release. “The highly anticipated release of Persona revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient’s unique requirements.”